Table 1.
Profile of Study Participants
| Parameters | Number of participants | Percentage |
|---|---|---|
| Age | ||
| Mean age in years (age range) | 35 (22–70) | |
| Gender | ||
| Male | 24 | 38 |
| Female | 39 | 62 |
| Marital status | ||
| Married | 39 | 62 |
| Divorced | 2 | 3 |
| Separated | 8 | 13 |
| Single | 14 | 22 |
| Nationality | ||
| Kenyan | 63 | 100 |
| Partner's HIV status | ||
| Concordant HV status | 20 | 32 |
| Discordant HIV status | 21 | 33 |
| Don't know | 22 | 35 |
| Partner on antiretroviral therapy | ||
| Yes | 16 | 25 |
| No | 5 | 8 |
| Don't know | 42 | 67 |
| Sexual preferences | ||
| Heterosexual | 60 | 95 |
| Homosexual | 1 | 2 |
| Bisexual | 0 | 0 |
| Abstaining | 2 | 3 |
| Undeclared | 0 | 0 |
| WHO staging | ||
| Stage 1 | 58 | 92 |
| Stage 2 | 3 | 5 |
| Stage 3 | 2 | 3 |
| Stage 4 | 0 | 0 |
The details are presented for 63 treatment-naive patients from whom the protease gene was successfully amplified.